Narcolepsy Clinical Trials

130 clinical trials for Narcolepsy across international registries, including 21 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy — RECRUITING · PHASE3
• A Trial to Test the Safety and Tolerability of Lu AH69593 in Adults That Are Healthy or Have Narcolepsy — RECRUITING · PHASE1
• Decreasing Nightmares in Adults With Narcolepsy — RECRUITING · NA
• WAKIX® (Pitolisant) Pregnancy Registry — RECRUITING
• Cardiovascular and Cognitive Implications of Central Disorders of Hypersomnolence and Their Treatments — RECRUITING
• Evaluation of Social Cognition in Patient With Type 1 or Type 2 Narcolepsy Versus Patients With Idiopathic Hypersomnia — RECRUITING · NA
• A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy — RECRUITING · PHASE2
• Proteomics and Metabolomics of Body Fluid in Patients With Narcolepsy — RECRUITING
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALKS 2680 IN ADULTS WITH NARCOLEPSY TYPE 1 — RECRUITING · PHASE3
• Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research — RECRUITING
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF E2086 IN ADULTS WITH NARCOLEPSY — RECRUITING
• A LONG-TERM EXTENSION STUDY OF THE SAFETY AND EFFICACY OF CLEMINOREXTON IN PARTICIPANTS WITH NARCOLEPSY AND IDIOPATHIC HYPERSOMNIA WHO COMPLETED A SPONSORED CLEMINOREXTON CLINICAL TRIAL — RECRUITING
• A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF ORX750 IN SUBJECTS WITH NARCOLEPSY AND IDIOPATHIC HYPERSOMNIA ¿ (CRYSTAL-1) — RECRUITING · PHASE2
• The Impact of Light, Electrical, and Magnetic Neuroregulation Interventions on Sleep-wake Disorders — RECRUITING · NA
• Child and Adolescent Registry for Participants With Narcolepsy — RECRUITING
• A LONG-TERM EXTENSION STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF TAK-861 IN PARTICIPANTS WITH SELECTED CENTRAL HYPERSOMNIA CONDITIONS — RECRUITING
• SUNOSI® (Solriamfetol) Pregnancy Registry — RECRUITING
• Mainz Register of Patients With Sleep Disorders — RECRUITING
• A STUDY TO ASSESS THE LONG-TERM EFFICACY AND SAFETY OF AXS-12 IN THE TREATMENT OF CATAPLEXY AND EXCESSIVE DAYTIME SLEEPINESS IN SUBJECTS WITH NARCOLEPSY — RECRUITING
• RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF AXS-12 IN THE TREATMENT OF CATAPLEXY AND EXCESSIVE DAYTIME SLEEPINESS IN SUBJECTS WITH NARCOLEPSY — RECRUITING
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE RISING ORAL DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF TAK-994 IN PATIENTS WITH NARCOLEPSY WITH OR WITHOUT CATAPLEXY (NARCOLEPSY TYPE 1 OR NARCOLEPSY TYPE 2) — RECRUITING
• Hypersomnia in the Paediatric Population — NOT_YET_RECRUITING · NA
• A first-in-human, randomized, double-blind, placebo-controlled, three-part study assessing the safety, tolerability, pharmacokinetics and pharmacodynamics of BP1.15205 after single and repeated oral ascending doses, including the BP1.15205 effect on cardiac repolarization, as well as an exploratory assessment of the food effect on the pharmacokinetics of BP1.15205 in healthy participants — TERMINATED · PHASE1
• A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of E2086 in Adults with Narcolepsy — NOT_YET_RECRUITING · PHASE2
• A trial to test the safety and tolerability of Lu AH70212 and Lu AH69593 in healthy adults. — TERMINATED · PHASE1
• Spectrometry (MRM) Versus I 125 Radioimmunoassay (RIA) for Quantification of Orexin-A of Patients With Hypersomnolence — COMPLETED · NA
• Narcolepsy Nightmare Study — COMPLETED · NA
• A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy (AWAKE) — NOT_YET_RECRUITING · PHASE3
• Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT) — COMPLETED · PHASE2
• Study of Psychological, Sociological and Professional Factors Associated With Maintenance of Wakefulness Test — COMPLETED
• A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH — NOT_YET_RECRUITING · PHASE3
• A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy — COMPLETED · PHASE3
• A study to test the safety and tolerability of Lu AH69593 in adults that are healthy or have narcolepsy. — TERMINATED · PHASE1
• Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies — COMPLETED · NA
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EFFICACY AND SAFETY STUDY OF HBS-301 IN PARTICIPANTS WITH NARCOLEPSY FOLLOWED BY AN OPEN-LABEL EXTENSION — NOT_YET_RECRUITING · PHASE3
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALKS 2680 IN ADULTS WITH NARCOLEPSY TYPE 1 — NOT_YET_RECRUITING · PHASE3
• A Switch Study From High-Sodium Oxybate to Xywav to Evaluate Changes in Blood Pressure in Participants With Narcolepsy — COMPLETED · PHASE4
• Study of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004) — TERMINATED · PHASE1
• A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1 — TERMINATED · PHASE1
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALKS 2680 IN ADULTS WITH NARCOLEPSY TYPE 2 — NOT_YET_RECRUITING · PHASE3
• Observational Study of LUMRYZ in Narcolepsy — COMPLETED
• Metabolism Characteristics in the Children With Narcolepsy — COMPLETED · NA
• A Study of HBS-201 (Pitolisant Delayed-release) — COMPLETED · PHASE1
• A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE) — COMPLETED · PHASE3
• An Open Label Study of FT218 in Subjects With Narcolepsy — COMPLETED · PHASE3
• A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy — COMPLETED · PHASE4
• Double blind, multicentre, randomized, placebo-controlled trial to evaluate safety and efficacy of pitolisant in children from 6 to less than 18 years with narcolepsy with/without cataplexy, followed by a prolonged open-label period — OTHER · PHASE3
• An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV — OTHER · PHASE3
• A Study to Evaluate the Safety and Efficacy of TS-091 in Patients with Narcolepsy — COMPLETED · PHASE2
• Advancing Understanding of Transportation Options — COMPLETED · NA

Refine this search